{"id":"W2591276563","doi":"10.1002/acr.23233","title":"Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study","year":2017,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"Genentech; Celgene; Sanofi; Pfizer","keywords":"Secukinumab; Medicine; Ankylosing spondylitis; Placebo; Adverse effect; Clinical endpoint; Internal medicine; Randomized controlled trial; Gastroenterology; Rheumatoid arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002702026,0.0002110651,0.0005502739,0.000166061,0.0004245062,0.0001097662,0.0001154496,0.00006150657,0.00003395975],"category_scores_gemma":[0.0002060536,0.0001868816,0.00003621689,0.0001557498,0.0004961299,0.0003011104,0.0003854248,0.000296373,0.000001249652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001860489,"about_ca_system_score_gemma":0.0001134347,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01446034,"about_ca_topic_score_gemma":0.009435912,"domain_scores_codex":[0.9975603,0.0001220825,0.0003750368,0.0006616638,0.0007504366,0.0005305259],"domain_scores_gemma":[0.9983464,0.0001822174,0.0001400238,0.0006291475,0.0005532206,0.0001489478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01454019,0.002030962,0.3135173,0.00004424058,0.000343734,0.00191025,0.05628081,1.605807e-7,0.0002418356,0.00005013821,0.0000203871,0.61102],"study_design_scores_gemma":[0.2080716,0.02381442,0.6919942,0.001034279,0.00006746798,0.000007142442,0.07342537,0.000004689164,0.0007581768,0.0001587276,0.0004249921,0.0002388114],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926545,0.002022645,9.942805e-7,0.00007853666,0.00003947173,0.002356758,0.002118534,0.00001381072,0.0007147361],"genre_scores_gemma":[0.9989033,0.000418774,0.000091869,0.00001528503,0.00005295845,0.0001322484,0.0003233485,0.0000304629,0.00003176678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6107812,"threshold_uncertainty_score":0.9921024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02682826086176169,"score_gpt":0.365604717089153,"score_spread":0.3387764562273913,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}